New flu jab a ‘dream come true’

Megan Haggan 21/11/2025

flu vaccination: the virus close-up in blue

An mRNA based flu vaccine, which has been developed by Pfizer, is 34.5% more effective against influenza-like illness compared to current flu vaccines, according to a new trial But the new vaccine “was associated with more reactogenicity events,” the authors note. Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine, published in the New England

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

New flu jab a ‘dream come true’

Previous Minister revokes pharmacy’s approval

Next Ageism a factor in polypharmacy

MENU

ajp.com.au

Previous Minister revokes pharmacy’s approval

Next Ageism a factor in polypharmacy

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.